2m 2m 2m 2m 2m 2m 2m
FORTE BIOSCIENC (FBRX)
NASDAQ
$43.25-$0.87 (-1.97%)
Price as of Jul 14, 2026 4:04 PM EDT- $903.5MMarket Cap
- 348.60%1-Year Change
- BiotechnologyIndustry
FORTE BIOSCIENC (FBRX)
$43.25-$0.87 (-1.97%)
FBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $44.12 | ||
Change | +$0.20 (+0.46%) | ||
Open | $43.60 | ||
High | $44.37 | ||
Low | $40.11 | ||
Previous Close | $43.92 | ||
Volume | 742,886 | ||
30-Day Average Volume | 870,133 | ||
1-Week Change | 116.17% | ||
1-Month Change | 151.25% | ||
1-Year Change | 348.60% | ||
3-Year Change | 74.73% | ||
5-Year Change | -94.71% | ||
Fundamentals | |||
Shares Outstanding | 20.5M | ||
Total Assets | $67.2M | ||
Market Cap | $903.5M | ||
Enterprise Value | $845.3M | ||
Period: QTR TTM FY | |||
Revenue | -$7,000.00 | ||
Net Income | -$22.1M | ||
Free Cash Flow | -$18.8M | ||
EBIT | -$21.8M | ||
EBITDA | -$21.7M | ||
Net Working Capital | $41.5M | ||
EPS | -$1.24 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | -120,758 | ||
P/B | 21 | ||
P/E | -36 | ||
PEG | N/A | ||
Price/Free Cash Flow | -48 | ||
Price/Operating Cash Flow | -48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/28/2024 | ||
Earnings & Revenue